SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $506,000 | -37.6% | 70,938 | -43.0% | 0.00% | -33.3% |
Q2 2014 | $811,000 | -4.7% | 124,391 | -3.4% | 0.01% | 0.0% |
Q1 2014 | $851,000 | +39.5% | 128,768 | 0.0% | 0.01% | +50.0% |
Q4 2013 | $610,000 | -4.5% | 128,768 | 0.0% | 0.00% | -20.0% |
Q3 2013 | $639,000 | +84.7% | 128,768 | +92.9% | 0.01% | +66.7% |
Q2 2013 | $346,000 | – | 66,768 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |